Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

170.23
Delayed Data
As of Aug 25
 -0.61 / -0.36%
Today’s Change
130.09
Today|||52-Week Range
176.64
+4.87%
Year-to-Date
Amgen's Shameful Silence Covers Up Reasons for FDA Drug Rejection
Aug 25 / TheStreet.com - Paid Partner Content
3 Cheap Dividend Stocks You Can Buy Right Now
Aug 19 / MotleyFool.com - Paid Partner Content
Amgen Gets CRL for Secondary Hyperparathyroidism Drug
Aug 25 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
Aug 24 / Zacks.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010
Aug 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close170.84
Today’s open169.92
Day’s range168.76 - 171.46
Volume2,623,837
Average volume (3 months)2,853,876
Market cap$127.8B
Dividend yield2.35%
Data as of 08/25/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+9.46%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.49%
P/E ratio17.4
Price/Sales5.83
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.42-0.52%
BIIBBiogen-2.48-0.80%
BAXBaxter International...+0.04+0.08%
ILMNIllumina Inc-0.06-0.04%
Data as of 08/25/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$2.80
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers

Search for Jobs